|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hiyama T, Yoshihara M, Tanaka S and
Chayama K: Genetic polymorphisms and esophageal cancer risk. Int J
Cancer. 121:1643–1658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Law S and Wong J: The current management
of esophageal cancer. Adv Surg. 41:93–119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang JY, Looi KS and Tan EM:
Identification of tumor-associated antigens as diagnostic and
predictive biomarkers in cancer. Methods Mol Biol. 520:1–10. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu BC, Wang LD and Pei H:
Tumor-associated autoantibody measurement for screening esophageal
cancer. J Clin Exp Med. 2007.
|
|
8
|
Dai L, Ren P, Liu M, Imai H, Tan EM and
Zhang J: Using immunomic approach to enhance tumor-associated
autoantibody detection in diagnosis of hepatocellular carcinoma.
Clin Immunol. 152:127–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anderson KS and LaBaer J: The sentinel
within: Exploiting the immune system for cancer biomarkers. J
Proteome Res. 4:1123–1133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mroczko B, Kozłowski M, Groblewska M,
Łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L and
Szmitkowski M: The diagnostic value of the measurement of matrix
metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and
carcinoembryonic antigen (CEA) in the sera of esophageal cancer
patients. Clin Chim Acta. 389:61–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Łukaszewicz-Zając M, Mroczko B, Kozłowski
M, Nikliński J, Laudański J and Szmitkowski M: Higher importance of
interleukin 6 than classic tumor markers (carcinoembryonic antigen
and squamous cell cancer antigen) in the diagnosis of esophageal
cancer patients. Dis Esophagus. 25:242–249. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asaga S, Kuo C, Nguyen T, Terpenning M,
Giuliano AE and Hoon DS: Direct serum assay for microRNA-21
concentrations in early and advanced breast cancer. Clin Chem.
57:84–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang L, Cheng Q, Zhang BH and Zhang MZ:
Circulating microRNAs as biomarkers in hepatocellular carcinoma
screening: A validation set from China. Medicine (Baltimore).
94:e6032015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Z, Zhao C and Wang Z: MicroRNAs as
ideal biomarkers for the diagnosis of lung cancer. Tumour Biol.
35:10395–10407. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan L, Zhao W, Yu H, Wang Y, Liu Y and Xie
C: A comprehensive meta-analysis of MicroRNAs for predicting
colorectal cancer. Medicine (Baltimore). 95:e27382016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hou C, Tan G and Feng S: Clinical
significance of microRNA expressions in diagnosing uterine cancer
and predicting lymph node metastasis. Tumour Biol. 35:10789–10798.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qu S, Guan J and Liu Y: Identification of
microRNAs as novel biomarkers for glioma detection: A meta-analysis
based on 11 articles. J Neurol Sci. 348:181–187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu F, Tian T, Xia LL, Ding Y, Cormier RT
and He Y: Circulating miRNAs as novel potential biomarkers for
esophageal squamous cell carcinoma diagnosis: A meta-analysis
update. Dis Esophagus. 30:1–9. 2017. View Article : Google Scholar
|
|
22
|
Li B, Yu Q, Shi Z, Li P and Fu S:
Circulating microRNAs in esophageal squamous cell carcinoma:
Association with locoregional staging and survival. Int J Clin Exp
Med. 8:7241–7250. 2015.PubMed/NCBI
|
|
23
|
Komatsu S, Ichikawa D, Takeshita H,
Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H,
Shiozaki A, et al: Circulating microRNAs in plasma of patients with
oesophageal squamous cell carcinoma. Br J Cancer. 105:104–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, Liu X, Ke Y, Si J and Zhou T: MiR-375 frequently
downregulated in gastric cancer inhibits cell proliferation by
targeting JAK2. Cell Res. 20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F,
Shen Y, Lu W, Wan X and Xie X: miR-375 is down-regulated in
squamous cervical cancer and inhibits cell migration and invasion
via targeting transcription factor SP1. Am J Pathol. 179:2580–2588.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M and
Moriyama M: MicroRNA-375 is downregulated in gastric carcinomas and
regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer
Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumors. 7th edition.
Wiley-Blackwell; Oxford, UK: 2009
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dwamena B: MIDAS: Stata module for
meta-analytical integration of diagnostic test accuracy studies.
Stat Softw Components. 14:2007.
|
|
31
|
Reitsma JB, Glas AS, Rutjes AW, Scholten
RJ, Bossuyt PM and Zwinderman AH: Bivariate analysis of sensitivity
and specificity produces informative summary measures in diagnostic
reviews. J Clin Epidemiol. 58:982–990. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Akobeng AK: Understanding diagnostic tests
3: Receiver operating characteristic curves. Acta Paediatr.
96:644–647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo
L and Lu SH: The oncogenetic role of microRNA-31 as a potential
biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond).
121:437–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu R, Liao J, Yang M, Shi Y, Peng Y, Wang
Y, Pan E, Guo W, Pu Y and Yin L: Circulating miR-155 expression in
plasma: A potential biomarker for early diagnosis of esophageal
cancer in humans. J Toxicol Environ Health A. 75:1154–1162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Li Y, Wang C, Guan X, Chen X,
Zeng K and Zhang C and Zhang C: Sequencing and identification of
mircORNAs from a genome-wide expression profile in serum of
esophageal squamous cell carcinoma. J Clin Lab Sci. 2012.
|
|
37
|
Xie Z, Chen G, Huang J and Li Z: The
diagnostic significance of plasma miR-10 for esophageal cancer.
Guangdong Med J. 34:2465–2468. 2013.
|
|
38
|
Hui B, Chen X, Hui L, Xi R and Zhang X:
Serum miRNA expression in patients with esophageal squamous cell
carcinoma. Oncol Lett. 10:3008–3012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: A fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang B and Zhang Q: The expression and
clinical significance of circulating microRNA-21 in serum of five
solid tumors. J Cancer Res Clin Oncol. 138:1659–1666. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirajima S, Komatsu S, Ichikawa D,
Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata
H, Kawaguchi T, et al: Clinical impact of circulating miR-18a in
plasma of patients with oesophageal squamous cell carcinoma. Br J
Cancer. 108:1822–1829. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sharma P, Saraya A, Gupta P and Sharma R:
Decreased levels of circulating and tissue miR-107 in human
esophageal cancer. Biomarkers. 18:322–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takeshita N, Hoshino I, Mori M, Akutsu Y,
Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, et
al: Serum microRNA expression profile: miR-1246 as a novel
diagnostic and prognostic biomarker for oesophageal squamous cell
carcinoma. Br J Cancer. 108:644–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang T, Zhao D, Wang Q, Yu X, Cui Y, Guo
L and Lu SH: MicroRNA-1322 regulates ECRG2 allele specifically and
acts as a potential biomarker in patients with esophageal squamous
cell carcinoma. Mol Carcinog. 52:581–590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Komatsu S, Ichikawa D, Hirajima S,
Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H,
Shiozaki A, et al: Plasma microRNA profiles: Identification of
miR-25 as a novel diagnostic and monitoring biomarker in
oesophageal squamous cell carcinoma. Br J Cancer. 111:1614–1624.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X,
Zhang Y, Chen X, Wang J, Zen K, et al: Diagnostic and prognostic
implications of a serum miRNA panel in oesophageal squamous cell
carcinoma. PLoS One. 9:e922922014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He FC, Meng WW, Qu YH, Zhou MX, He J, Lv P
and Ming L: Expression of circulating microRNA-20a and let-7a in
esophageal squamous cell carcinoma. World J Gastroenterol.
21:4660–4665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jiang Z, Song Q, Yang S, Zeng R, Li X,
Jiang C, Ding W, Zhang J and Zheng Y: Serum microRNA-218 is a
potential biomarker for esophageal cancer. Cancer Biomark.
15:381–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu H, Yao Y, Meng F, Qian X, Jiang X, Li
X, Gao Z and Gao L: Predictive value of serum miR-10b, miR-29c, and
miR-205 as promising biomarkers in esophageal squamous cell
carcinoma screening. Medicine (Baltimore). 94:e15582015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guan S, Wang C, Chen X, Liu B, Tan B, Liu
F, Wang D, Han L, Wang L, Huang X, et al: miR-613: A novel
diagnostic and prognostic biomarker for patients with esophageal
squamous cell carcinoma. Tumour Biol. 37:4383–4391. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun L, Dong S, Dong C, Sun K, Meng W, Lv
P, Yin H, Ming L and He F: Predictive value of plasma miRNA-718 for
esophageal squamous cell carcinoma. Cancer Biomark. 16:265–273.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ye M, Ye P, Zhang W, Rao J and Xie Z:
Diagnostic values of salivary versus and plasma microRNA-21 for
early esophageal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 34:885–889.
2014.(In Chinese). PubMed/NCBI
|
|
53
|
Li BX, Shi ZL, Yu Q and Fu S: Dynamic
monitoring of miR-21 in peripheral blood before and after
radiotherapy in patients with esophageal carcinoma and its clinical
implication. Tumor. 35:550–555. 2015.
|
|
54
|
Whiting PF, Rutjes AW, Westwood ME,
Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA and Bossuyt
PM: QUADAS-2 Group: QUADAS-2: A revised tool for the quality
assessment of diagnostic accuracy studies. Ann Intern Med.
155:529–536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kosaka N, Iguchi H, Yoshioka Y, Takeshita
F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular
transfer of microRNAs in living cells. J Biol Chem.
285:17442–17452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Redshaw N, Wilkes T, Whale A, Cowen S,
Huggett J and Foy CA: A comparison of miRNA isolation and RT-qPCR
technologies and their effects on quantification accuracy and
repeatability. Biotechniques. 54:155–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang Y, Wang Q, Zhang N, Ma H, Gu Y, Tang
H, Xu Z and Gao Y: Identification of microRNAs as novel biomarkers
for detecting esophageal squamous cell carcinoma in Asians: A
meta-analysis. Tumor Biol. 35:11595–11604. 2014. View Article : Google Scholar
|
|
59
|
Wan J, Wu W, Che Y, Kang N and Zhang R:
Insights into the potential use of microRNAs as a novel class of
biomarkers in esophageal cancer. Dis Esophagus. 29:412–420. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ma WJ, Lv GD, Tuersun A, Liu Q, Liu H,
Zheng ST, Huang CG, Feng JG, Wang X, Lin RY, et al: Role of
microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell
carcinoma. Mol Biol Rep. 38:3253–3260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lu Z, Liu M, Stribinskis V, Klinge CM,
Ramos KS, Colburn NH and Li Y: MicroRNA-21 promotes cell
transformation by targeting the programmed cell death 4 gene.
Oncogene. 27:4373–4379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Sayed D, Rane S, Lypowy J, He M, Chen IY,
Vashistha H, Yan L, Malhotra A, Vatner D and Abdellatif M:
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol
Biol Cell. 19:3272–3282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Schramedei K, Mörbt N, Pfeifer G, Läuter
J, Rosolowski M, Tomm JM, von Bergen M, Horn F and Brocke-Heidrich
K: MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.
Oncogene. 30:2975–2985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kurashige J, Kamohara H, Watanabe M,
Tanaka Y, Kinoshita K, Saito S, Hiyoshi Y, Iwatsuki M, Baba Y and
Baba H: Serum microRNA-21 is a novel biomarker in patients with
esophageal squamous cell carcinoma. J Surg Oncol. 106:188–192.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Komatsu S, Ichikawa D, Takeshita H,
Konishi H, Nagata H, Hirajima S, Kawaguchi T, Arita T, Shiozaki A,
Fujiwara H, et al: Prognostic impact of circulating miR-21 and
miR-375 in plasma of patients with esophageal squamous cell
carcinoma. Expert Opin Biol Ther. 12 Suppl 1:S53–S59. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Avissar M, Christensen BC, Kelsey KT and
Marsit CJ: MicroRNA expression ratio is predictive of head and neck
squamous cell carcinoma. Clin Cancer Res. 15:2850–2855. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Mathé EA, Nguyen GH, Bowman ED, Zhao Y,
Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, et
al: MicroRNA expression in squamous cell carcinoma and
adenocarcinoma of the esophagus: Associations with survival. Clin
Cancer Res. 15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Miko E, Czimmerer Z, Csánky E, Boros G,
Buslig J, Dezso B and Scholtz B: Differentially expressed microRNAs
in small cell lung cancer. Exp Lung Res. 35:646–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H,
Wang W, Zhang L, Zhang X, Tang Q, et al: MicroRNA-25 functions as a
potential tumor suppressor in colon cancer by targeting Smad7.
Cancer Lett. 335:168–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Esposito F, Tornincasa M, Pallante P,
Federico A, Borbone E, Pierantoni GM and Fusco A: Down-regulation
of the miR-25 and miR-30d contributes to the development of
anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J
Clin Endocrinol Metab. 97:E710–E718. 2012. View Article : Google Scholar : PubMed/NCBI
|
